Exenatide remains effective but is generally less potent in both glycemic and weight outcomes, which has limited its current use (Thomsen et al., 2025)
Don't be afraid to ask questions, whether it's about managing side effects, optimizing your diet, or understanding how GLP-1 and Zepbound work long-term
Polzin DJ, Osborne CA, Adams LG, Lulich JP
35 FreoU.FurnariM.AmbrosioF.CalcarellaG.BrianiC
Pharmaceutical-Grade Retatrutide from Canada Clinical trials show 24.2% average fat loss with this triple-action GLP-1/GIP/glucagon receptor agonist
27% of Gen Z Americans struggle to get a GLP-1 prescription more than twice the rate of their UK peers (13%)